Though Ultraviolet B radiation (290-320 nm; UVB) exerts profound systemic effects, it is absorbed only in the epidermis. One important question in photobiology is how UVB signals are emanated from the epidermis. Microvesicle particles (MVP) are small (200-1000nm diameter) membranebound vesicles released by numerous cell types and can be found in the circulation. MVP can contain both nuclear and cytoplasmic components and are thought to provide a mechanism by which cells transmit signals systemically. Though various stressors have been demonstrated to generate MVP, the ability of UVB to exert this effect has not been demonstrated. Previous studies from ours and other groups have established that through its ability to act as a pro-oxidative stressor, UVB generates oxidized glycerophosphocholine (Ox-GPC) lipids with Platelet-activating Factorreceptor (PAF-R) agonist activity. Our first studies examined the ability of UVB to stimulate the release of MVP. Treatment of the human keratinocytederived cell line HaCaT with UVB resulted in the release of MVP. Treatment of HaCaT cells with the PAF-R agonist carbamoyl-PAF (CPAF) also generated MVP release. Preincubation of HaCaT cells with antioxidants N-acetyl cysteine and vitamin C blocked MVP release in response to UVB, but had no effect on MVP release in response to CPAF. To confirm that UVB generates MVP via PAF-R agonists, we used a human epithelial cell line with/without PAF-Rs. UVB generated MVP only in the PAF-R-expressing (KBP) not the PAF-R-negative (KBM) cells. Finally, we induced suction blisters on human skin explants and human skin in vivo and tested the ability of UVB irradiation of these blisters to induce MVP release into blister fluid. These experiments determined that UVB generated MVP in human skin. These studies describe a new pathway involving MVP generated following UVB-induced PAF agonist formation that could play an important role in transmitting systemic signals following this environmental pro-oxidative stressor. 
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3. As MVP are thought to be functional signaling agents, these studies could provide a mechanism whereby UVB can generate systemic effects. . At various times posttreatment supernatants were removed and MVP isolated using differential centrifugation and quantified using a NanoSight NS300 instrument using our previously published protocol [8, 10] .
SUMMARY
For ex vivo experiments, we used skin discarded from human abdominoplasty experiments. The skin was warmed to~37-38 degrees C and suction blisters separating epidermis from dermis were created using vacuum pumps and syringes (see Fig 5) . 
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These include marked vasodilatory effects, increased vascular permeability, bronchoconstriction, and platelet activation. PAF has also been implicated in sepsis [1,2]. PAF acts by binding to a cellular heterotrimeric G-protein coupled receptor PAF-R. This receptor is found on many cell types including granulocytes, B-cells, epithelial cells (keratinocytes), and some mesenchymal cells. PAF-R activation is known to induce intracellular calcium mobilization and is expressed on keratinocytes. Recent studies have demonstrated that PAF can be produced both enzymatically and through non-enzymatic oxidation of membrane glycerophosphocholines (ox-GPCs) [3]
. Given that PAF is involved in UVB-mediated acute effects, these studies were designed to define if MVP are released from keratinocytes following UVB, and if PAF was involved in this process. A). Ex vivo blisters were treated with UVB (1 or 2.5 KJ/m2 or DMSO or CPAF (100 or 1000 ng). B). In vivo blisters were treated with sham or UVB (1KJ/m2). MVP tested at 2h.
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UVB generates microvesicle particles via Platelet-activating Factor-receptor signaling: a novel pathway by which a skin-specific stimulus exerts systemic effects
